Antagonists of PCSK9

Details for Australian Patent Application No. 2007322265 (hide)

Owner Merck & Co., Inc.

Inventors Hammond, Holly A.; Pandit, Shilpa; Sparrow, Carl P.; Sitlani, Ayesha; Condra, Jon H.

Agent Spruson & Ferguson

Pub. Number AU-A-2007322265

PCT Pub. Number WO2008/063382

Priority 60/857,293 07.11.06 US; 60/857,248 07.11.06 US

Filing date 2 November 2007

Wipo publication date 29 May 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/063382 Priority application(s): WO2008/063382

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007322268-Boronic acids and esters as inhibitors of fatty acid amide hydrolase

2007322262-Automatic card handling device and communication network